These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7888574)

  • 1. Photochemical immobilization of heparin, dermatan sulphate, dextran sulphate and endothelial cell surface heparan sulphate onto cellulose membranes for the preparation of athrombogenic and antithrombogenic polymers.
    Erdtmann M; Keller R; Baumann H
    Biomaterials; 1994 Oct; 15(13):1043-8. PubMed ID: 7888574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Which glycosaminoglycans are suitable for antithrombogenic or athrombogenic coatings of biomaterials? Part II: Covalently immobilized endothelial cell surface heparan sulfate (ESHS) and heparin (HE) on synthetic polymers and results of animal experiments.
    Baumann H; Keller R
    Semin Thromb Hemost; 1997; 23(2):215-23. PubMed ID: 9200349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Which glycosaminoglycans are suitable for antithrombogenic or athrombogenic coatings of biomaterials? Part I: Basic concepts of immobilized GAGs on partially cationized cellulose membrane.
    Baumann H; Mueller U; Keller R
    Semin Thromb Hemost; 1997; 23(2):203-13. PubMed ID: 9200348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells.
    Vischer P; Feitsma K; Schön P; Völker W
    Eur J Cell Biol; 1997 Aug; 73(4):332-43. PubMed ID: 9270876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface modification of the polymers present in a polysulfone hollow fiber hemodialyser by covalent binding of heparin or endothelial cell surface heparan sulfate: flow characteristics and platelet adhesion.
    Baumann H; Kokott A
    J Biomater Sci Polym Ed; 2000; 11(3):245-72. PubMed ID: 10841278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human vascular endothelial cells catabolise exogenous glycosaminoglycans by a novel route.
    Dawes J; Pepper DS
    Thromb Haemost; 1992 Apr; 67(4):468-72. PubMed ID: 1378652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the activity of a heparan sulphate of defined molecular weight range (7500-15,000 Da) with heparin and dermatan sulphate.
    Gervasi GB; Catalani R; Bartoli C; Carpita G; Farina C; Gelso E
    Pharmacol Res; 1995 Jun; 31(6):331-6. PubMed ID: 8685069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of regioselectively sulfated and acetylated polysaccharide coatings of biomaterials for reducing platelet and plasma protein adhesion.
    Baumann H
    Semin Thromb Hemost; 2001 Oct; 27(5):445-63. PubMed ID: 11668414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a platelet endoglycosidase on cell surface associated heparan sulphate of human culturei endothelial and glial cells.
    Wasteson A; Glimelius B; Busch C; Westermark H; Heldin CH; Norling B
    Thromb Res; 1977 Sep; 11(3):309-21. PubMed ID: 144331
    [No Abstract]   [Full Text] [Related]  

  • 10. Systematic protein interactome analysis of glycosaminoglycans revealed YcbS as a novel bacterial virulence factor.
    Hsiao FS; Sutandy FR; Syu GD; Chen YW; Lin JM; Chen CS
    Sci Rep; 2016 Jun; 6():28425. PubMed ID: 27323865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical bases of the interaction of human basic fibroblast growth factor with glycosaminoglycans. New insights from trypsin digestion studies.
    Coltrini D; Rusnati M; Zoppetti G; Oreste P; Isacchi A; Caccia P; Bergonzoni L; Presta M
    Eur J Biochem; 1993 May; 214(1):51-8. PubMed ID: 8508806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of tailor-made collagen-glycosaminoglycan matrices: EDC/NHS crosslinking, and ultrastructural aspects.
    Pieper JS; Hafmans T; Veerkamp JH; van Kuppevelt TH
    Biomaterials; 2000 Mar; 21(6):581-93. PubMed ID: 10701459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collagen-based modified membranes for tissue engineering: influence of type and molecular weight of GAGs on cell proliferation.
    Ruozi B; Parma B; Croce MA; Tosi G; Bondioli L; Vismara S; Forni F; Vandelli MA
    Int J Pharm; 2009 Aug; 378(1-2):108-15. PubMed ID: 19501149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of high ambient glucose level on the production of pericellular glycosaminoglycans by cultured endothelial cells.
    Yevdokimova NY; Komisarenko SV
    Ukr Biokhim Zh (1999); 2003; 75(5):55-62. PubMed ID: 14681993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased sulphation improves the anticoagulant activities of heparan sulphate and dermatan sulphate.
    Ofosu FA; Modi GJ; Blajchman MA; Buchanan MR; Johnson EA
    Biochem J; 1987 Dec; 248(3):889-96. PubMed ID: 2963622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet endothelial cell adhesion molecule 1 (PECAM-1) and its interactions with glycosaminoglycans: 2. Biochemical analyses.
    Coombe DR; Stevenson SM; Kinnear BF; Gandhi NS; Mancera RL; Osmond RI; Kett WC
    Biochemistry; 2008 Apr; 47(17):4863-75. PubMed ID: 18327914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of glycosaminoglycan chains from different proteoglycan populations in human embryonic skin fibroblasts.
    Schmidtchen A; Fransson LA
    Eur J Biochem; 1992 Sep; 208(2):537-46. PubMed ID: 1521543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermatan sulfate is the predominant antithrombotic glycosaminoglycan in vessel walls: implications for a possible physiological function of heparin cofactor II.
    Tovar AM; de Mattos DA; Stelling MP; Sarcinelli-Luz BS; Nazareth RA; Mourão PA
    Biochim Biophys Acta; 2005 Apr; 1740(1):45-53. PubMed ID: 15878740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can we produce heparin/heparan sulfate biomimetics using "mother-nature" as the gold standard?
    Farrugia BL; Lord MS; Melrose J; Whitelock JM
    Molecules; 2015 Mar; 20(3):4254-76. PubMed ID: 25751786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased deposition of glycosaminoglycans and altered structure of heparan sulfate in idiopathic pulmonary fibrosis.
    Westergren-Thorsson G; Hedström U; Nybom A; Tykesson E; Åhrman E; Hornfelt M; Maccarana M; van Kuppevelt TH; Dellgren G; Wildt M; Zhou XH; Eriksson L; Bjermer L; Hallgren O
    Int J Biochem Cell Biol; 2017 Feb; 83():27-38. PubMed ID: 27974233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.